Veracyte
VCYT
166 hedge funds and large institutions have $1.47B invested in Veracyte in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 53 increasing their positions, 63 reducing their positions, and 21 closing their positions.
115% more call options, than puts
Call options by funds: $1.13M | Put options by funds: $526K
7% more capital invested
Capital invested by funds: $1.38B → $1.47B (+$94.4M)
2.18% more ownership
Funds ownership: 114.12% → 116.3% (+2.2%)
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
1% more funds holding
Funds holding: 165 → 166 (+1)
16% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 63
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$44.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.8M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$18.6M |
| 4 |
BlackRock
New York
|
+$9.8M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.42M |
Top Sellers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$13.1M |
| 2 |
Goldman Sachs
New York
|
-$12.5M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$9.92M |
| 4 |
CC
Cannell Capital
Alta,
Wyoming
|
-$7.2M |
| 5 |
FA
Friess Associates
Greenville,
Delaware
|
-$6.02M |
VCYT Hedge Fund Activity: Q2 2020 in Review
166 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2020, worth a combined $1.47B — up 6.8% from $1.38B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new VCYT positions and 21 closed out — a net gain of 2 holders — while 53 added to existing stakes and 63 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $44.8M. The largest seller was Farallon Capital Management, cutting an estimated $13.1M.
- 166 institutional investors held Veracyte (VCYT) as of Q2 2020, up from 165 in Q1 2020.
- Funds reported $1.47B of Veracyte stock for Q2 2020, up 6.8% quarter-over-quarter.
- 23 funds opened new Veracyte positions in Q2 2020 and 21 closed out, a net change of +2 holders.
- The largest Veracyte buyer in Q2 2020 was ARK Investment Management, an estimated $44.8M added.
- The largest Veracyte seller in Q2 2020 was Farallon Capital Management, an estimated $13.1M sold.
Based on aggregated 13F filings for Q2 2020.